EV/EBITDA

Enterprise value to EBITDA (EV/EBITDA) compares a company’s total market value to its core operating earnings, with a lower multiple suggesting a cheaper valuation relative to earnings.

At 8.9x, XRAY trades well below the sector median of 13.7x and ranks in the 25th percentile among its sector peers, indicating it is among the least expensive companies in its industry. The year-over-year change is not available, but the quarter-over-quarter change shows a +17.6% increase from the prior quarter’s 7.6x, meaning the multiple has risen recently. While the low absolute level points to a possible value opportunity, the upward quarterly move could signal that the market is beginning to re-rate the stock higher, reducing the margin of safety. This combination of a cheap valuation with a rising trend introduces both potential upside from mean reversion and the risk that further appreciation may already be priced in. Given the neutral overall verdict, the metric neither strongly supports a bullish nor a bearish stance; the cheap relative level offers some support for holding, but the rapid quarterly rise warrants caution.

Frequently Asked Questions

Closest Sector Peers